Related references
Note: Only part of the references are listed.Heart failure in the patient with diabetes: Epidemiology, aetiology, prognosis, therapy and the effect of glucose-lowering medications
David S. H. Bell et al.
DIABETES OBESITY & METABOLISM (2019)
Mutual promotion of FGF21 and PPARγ attenuates hypoxia-induced pulmonary hypertension
Gexiang Cai et al.
EXPERIMENTAL BIOLOGY AND MEDICINE (2019)
Heart failure and diabetes: management and open issues
K. Schuett et al.
HERZ (2019)
Fibroblast growth factor-21 prevents diabetic cardiomyopathy via AMPK-mediated antioxidation and lipid-lowering effects in the heart
Hong Yang et al.
CELL DEATH & DISEASE (2018)
Neuronal Mitochondrial Dysfunction Activates the Integrated Stress Response to Induce Fibroblast Growth Factor 21
Lisa Michelle Restelli et al.
CELL REPORTS (2018)
Fibroblast Growth Factor 21-Metabolic Role in Mice and Men
Harald Staiger et al.
ENDOCRINE REVIEWS (2017)
Fibroblast growth factor 21 protects rat cardiomyocytes from endoplasmic reticulum stress by promoting the fibroblast growth factor receptor 1-extracellular signal-regulated kinase 1/2 signaling pathway
Pingping Liang et al.
INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE (2017)
Circulating levels of fibroblast growth factor 21 in early-stage diabetic kidney disease
A. Esteghamati et al.
IRISH JOURNAL OF MEDICAL SCIENCE (2017)
Troxerutin protects against diabetic cardiomyopathy through NF-κB/AKT/IRS1 in a rat model of type 2 diabetes
Yongzhi Yu et al.
MOLECULAR MEDICINE REPORTS (2017)
N-3 polyunsaturated fatty acids increase hepatic fibroblast growth factor 21 sensitivity via a PPAR-γ-β-klotho pathway
Wenqi Yang et al.
MOLECULAR NUTRITION & FOOD RESEARCH (2017)
Fibroblast growth factors (FGFs) in cancer: FGF traps as a new therapeutic approach
Marco Presta et al.
PHARMACOLOGY & THERAPEUTICS (2017)
FGF21 resistance is not mediated by downregulation of beta-klotho expression in white adipose tissue
Kathleen R. Markan et al.
MOLECULAR METABOLISM (2017)
Fibroblast growth factor 21 and its novel association with oxidative stress
Miguel Angel Gomez-Samano et al.
REDOX BIOLOGY (2017)
Fgf21 regulates T-cell development in the neonatal and juvenile thymus
Yoshiaki Nakayama et al.
SCIENTIFIC REPORTS (2017)
Decreased levels of Fibroblast Growth Factor 21 are correlated with improved hypoglycemia in patients with insulinoma
Xu Li et al.
SCIENTIFIC REPORTS (2017)
Activation of nuclear β-catenin/c-Myc axis promotes oxidative stress injury in streptozotocin-induced diabetic cardiomyopathy
Peng Liu et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2017)
Transforming growth factor beta (TGF-β) mediates cardiac fibrosis and induces diabetic cardiomyopathy
Yiyang Yue et al.
DIABETES RESEARCH AND CLINICAL PRACTICE (2017)
Oxidative toxicity in diabetes and Alzheimer's disease: mechanisms behind ROS/RNS generation
Waqar Ahmad et al.
JOURNAL OF BIOMEDICAL SCIENCE (2017)
Effects of insulin and exercise training on FGF21, its receptors and target genes in obesity and type 2 diabetes
Rikke Kruse et al.
DIABETOLOGIA (2017)
Modulation of energy balance by fibroblast growth factor 21
Daniel Cuevas-Ramos et al.
HORMONE MOLECULAR BIOLOGY AND CLINICAL INVESTIGATION (2017)
MiR-486 regulates cardiomyocyte apoptosis by p53-mediated BCL-2 associated mitochondrial apoptotic pathway
Yuhan Sun et al.
BMC CARDIOVASCULAR DISORDERS (2017)
An overview of the inflammatory signalling mechanisms in the myocardium underlying the development of diabetic cardiomyopathy
Giacomo Frati et al.
CARDIOVASCULAR RESEARCH (2017)
30 Years of NF-κB: A Blossoming of Relevance to Human Pathobiology
Qian Zhang et al.
CELL (2017)
Bioactive Components in Human Milk Along the First Month of Life: Effects of Iodine Supplementation during Pregnancy
Ines Velasco et al.
ANNALS OF NUTRITION AND METABOLISM (2016)
FGF21-FGFR1 Coordinates Phospholipid Homeostasis, Lipid Droplet Function, and ER Stress in Obesity
Min Ye et al.
ENDOCRINOLOGY (2016)
Hepatocyte β-Klotho regulates lipid homeostasis but not body weight in mice
Kanako Kobayashi et al.
FASEB JOURNAL (2016)
Fibroblast growth factor 21 attenuates hepatic fibrogenesis through TGF-β/smad2/3 and NF-κB signaling pathways
Pengfei Xu et al.
TOXICOLOGY AND APPLIED PHARMACOLOGY (2016)
Efficacy of CD34+ Stem Cell Therapy in Nonischemic Dilated Cardiomyopathy Is Absent in Patients With Diabetes but Preserved in Patients With Insulin Resistance
Bojan Vrtovec et al.
STEM CELLS TRANSLATIONAL MEDICINE (2016)
Resistin-induced cardiomyocyte hypertrophy is inhibited by apelin through the inactivation of extracellular signal-regulated kinase signaling pathway in H9c2 embryonic rat cardiomyocytes
Jian-Wei Luo et al.
BIOMEDICAL REPORTS (2016)
Additive protection by LDR and FGF21 treatment against diabetic nephropathy in type 2 diabetes model
Minglong Shao et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2015)
Myocardial Metabolism in Diabetic Cardiomyopathy: Potential Therapeutic Targets
Miranda M. Sung et al.
ANTIOXIDANTS & REDOX SIGNALING (2015)
Fibroblast Growth Factor 21 Prevents Atherosclerosis by Suppression of Hepatic Sterol Regulatory Element-Binding Protein-2 and Induction of Adiponectin in Mice
Zhuofeng Lin et al.
CIRCULATION (2015)
Fibroblast growth factor 21 protects the heart from apoptosis in a diabetic mouse model via extracellular signal-regulated kinase 1/2-dependent signalling pathway
Chi Zhang et al.
DIABETOLOGIA (2015)
NADPH oxidase NOX1 is involved in activation of protein kinase C and premature senescence in early stage diabetic kidney
Kai Zhu et al.
FREE RADICAL BIOLOGY AND MEDICINE (2015)
Fibroblast growth factor 21 (FGF21) ameliorates collagen-induced arthritis through modulating oxidative stress and suppressing nuclear factor-kappa B pathway
Yinhang Yu et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2015)
FGF21 deletion exacerbates diabetic cardiomyopathy by aggravating cardiac lipid accumulation
Xiaoqing Yan et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2015)
Effect of Brazilian green propolis in patients with type 2 diabetes: A double-blind randomized placebo-controlled study
Takuya Fukuda et al.
BIOMEDICAL REPORTS (2015)
Circulating FGF21 levels are related to nutritional status and metabolic but not hormonal disturbances in polycystic ovary syndrome
Magdalena Olszanecka-Glinianowicz et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2015)
Mitochondrial inefficiencies and anoxic ATP hydrolysis capacities in diabetic rat heart
Toan Pham et al.
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY (2014)
Cardiac Mitochondria and Reactive Oxygen Species Generation
Yeong-Renn Chen et al.
CIRCULATION RESEARCH (2014)
Angiotensin 1-7 Ameliorates Diabetic Cardiomyopathy and Diastolic Dysfunction in db/db Mice by Reducing Lipotoxicity and Inflammation
Jun Mori et al.
CIRCULATION-HEART FAILURE (2014)
Serum FGF21 concentration is associated with hypertriglyceridaemia, hyperinsulinaemia and pericardial fat accumulation, independently of obesity, but not with current coronary artery status
Yenna Lee et al.
CLINICAL ENDOCRINOLOGY (2014)
Fibroblast growth factor-21 enhances mitochondrial functions and increases the activity of PGC-1α in human dopaminergic neurons via Sirtuin-1
Johanna Makela et al.
SPRINGERPLUS (2014)
Glutathione and glutathione analogues; Therapeutic potentials
Jian Hui Wu et al.
BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS (2013)
Alpha-Lipoic Acid Treatment Reverses 2-Deoxy-D-ribose-Induced Oxidative Damage and Suppression of Insulin Expression in Pancreatic Beta-Cells
Gwanpyo Koh et al.
BIOLOGICAL & PHARMACEUTICAL BULLETIN (2013)
Proteomic study on the protective mechanism of fibroblast growth factor 21 to ischemia-reperfusion injury
Wei-Tao Cong et al.
CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY (2013)
Cardiac Dysfunction and Oxidative Stress in the Metabolic Syndrome: an Update on Antioxidant Therapies
Olesya Ilkun et al.
CURRENT PHARMACEUTICAL DESIGN (2013)
Hyperglycemia-Induced Protein Kinase C β2 Activation Induces Diastolic Cardiac Dysfunction in Diabetic Rats by Impairing Caveolin-3 Expression and Akt/eNOS Signaling
Shaoqing Lei et al.
DIABETES (2013)
FGF21 regulates metabolism and circadian behavior by acting on the nervous system
Angie L. Bookout et al.
NATURE MEDICINE (2013)
Endothelial CSN5 impairs NF-κB activation and Monocyte adhesion to endothelial cells and is highly expressed in human atherosclerotic lesions
Yaw Asare et al.
THROMBOSIS AND HAEMOSTASIS (2013)
Fibroblast growth factor 21 protects against cardiac hypertrophy in mice
A. Planavila et al.
NATURE COMMUNICATIONS (2013)
Puerarin protects differentiated PC12 cells from H2O2-induced apoptosis through the PI3K/Akt signalling pathway
Qin Zhang et al.
CELL BIOLOGY INTERNATIONAL (2012)
Understanding the Physical Interactions in the FGF21/FGFR/β-Klotho Complex: Structural Requirements and Implications in FGF21 Signaling
Junming Yie et al.
CHEMICAL BIOLOGY & DRUG DESIGN (2012)
FGF21 in ataxia patients with spinocerebellar atrophy and mitochondrial disease
Shih-Li Su et al.
CLINICA CHIMICA ACTA (2012)
Distinct Changes in Serum Fibroblast Growth Factor 21 Levels in Different Subtypes of Diabetes
Yang Xiao et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2012)
CD36 Inhibitors Reduce Postprandial Hypertriglyceridemia and Protect against Diabetic Dyslipidemia and Atherosclerosis
Alain Geloen et al.
PLOS ONE (2012)
Curcumin Alleviates Diabetic Cardiomyopathy in Experimental Diabetic Rats
Wei Yu et al.
PLOS ONE (2012)
The Role of Oxidative Stress in the Pathogenesis of Diabetic Vascular Complications
Shuji Sasaki et al.
DIABETES & METABOLISM JOURNAL (2012)
PPAR-γ and AMPK - Advantageous targets for myocardial ischemia/reperfusion therapy
Alex Morrison et al.
BIOCHEMICAL PHARMACOLOGY (2011)
AMPK activation, a preventive therapeutic target in the transition from cardiac injury to heart failure
Christophe Beauloye et al.
CARDIOVASCULAR RESEARCH (2011)
Fibroblast Growth Factor 21 Induces Glucose Transporter-1 Expression through Activation of the Serum Response Factor/Ets-Like Protein-1 in Adipocytes
Xuan Ge et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
Thermogenic Activation Induces FGF21 Expression and Release in Brown Adipose Tissue
Elayne Hondares et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
Endoplasmic Reticulum Stress As a Therapeutic Target in Cardiovascular Disease
Tetsuo Minamino et al.
CIRCULATION RESEARCH (2010)
Protective effect of lipoic acid against methotrexate-induced oxidative stress in liver mitochondria
Heena Tabassum et al.
FOOD AND CHEMICAL TOXICOLOGY (2010)
ER stress in cardiovascular disease
Tetsuo Minamino et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2010)
The Unfolded Protein Response in Health and Disease
Richard C. Austin
ANTIOXIDANTS & REDOX SIGNALING (2009)
Role of apoptosis in cardiovascular disease
Youngil Lee et al.
APOPTOSIS (2009)
Oxidative Stress and Total Antioxidant Capacity in Diabetic and Nondiabetic Acute Ischemic Stroke Patients
Baburhan Guldiken et al.
CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS (2009)
Rodent models of diabetic cardiomyopathy
Heiko Bugger et al.
DISEASE MODELS & MECHANISMS (2009)
FGF21 N- and C-termini play different roles in receptor interaction and activation
Junming Yie et al.
FEBS LETTERS (2009)
Molecular Pathology of the Fibroblast Growth Factor Family
Pavel Krejci et al.
HUMAN MUTATION (2009)
Diabetic β-Cells Can Achieve Self-Protection against Oxidative Stress through an Adaptive Up-Regulation of Their Antioxidant Defenses
Gregory Lacraz et al.
PLOS ONE (2009)
FGF21 induces PGC-1α and regulates carbohydrate and fatty acid metabolism during the adaptive starvation response
Matthew J. Potthoff et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
FGF21 is an Akt-regulated myokine
Yasuhiro Izumiya et al.
FEBS LETTERS (2008)
Cell death and endoplasmic reticulum stress: disease relevance and therapeutic opportunities
Inki Kim et al.
NATURE REVIEWS DRUG DISCOVERY (2008)
被撤回的出版物: Endoplasmic reticulum stress is involved in myocardial apoptosis of streptozocin-induced diabetic rats (Retracted Article. See vol 207, pg 123, 2010)
Zhenhua Li et al.
JOURNAL OF ENDOCRINOLOGY (2008)
Functional evolutionary history of the mouse Fgf gene family
Nobuyuki Itoh et al.
DEVELOPMENTAL DYNAMICS (2008)
Oxidative stress, AGE, and atherosclerosis
E. Schleicher et al.
KIDNEY INTERNATIONAL (2007)
Tanshinone IIA protects cardiac myocytes against oxidative stress-triggered damage and apoptosis
Jiajia Fu et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2007)
βKlotho is required for metabolic activity of fibroblast growth factor 21
Yasushi Ogawa et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Molecular insights into the klotho-dependent, endocrine mode of action of fibroblast growth factor 19 subfamily members
Regina Goetz et al.
MOLECULAR AND CELLULAR BIOLOGY (2007)
CD36 deficiency rescues lipotoxic cardiomyopathy
John Yang et al.
CIRCULATION RESEARCH (2007)
Cellular energy sensing and signaling by AMP-activated protein kinase
William W. Winder et al.
CELL BIOCHEMISTRY AND BIOPHYSICS (2007)
Regulation of cardiac growth and coronary angiogenesis by the Akt/PKB signaling pathway
Ichiro Shiojima et al.
GENES & DEVELOPMENT (2006)
Klotho converts canonical FGF receptor into a specific receptor for FGF23
Itaru Urakawa et al.
NATURE (2006)
Diastolic dysfunction and diabetic cardiomyopathy - Evaluation by Doppler echocardiography
Maurizio Galderisi
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2006)
Receptor specificity of the fibroblast growth factor family - The complete mammalian FGF family
Xiuqin Zhang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Fibroblast growth factor-21 improves pancreatic beta-cell function and survival by activation of extracellular signal-regulated kinase 1/2 and Akt signaling pathways
Wolf Wente et al.
DIABETES (2006)
Cellular signaling by fibroblast growth factor receptors
VP Eswarakumar et al.
CYTOKINE & GROWTH FACTOR REVIEWS (2005)
Regulation of cardiac long-chain fatty acid and glucose uptake by translocation of substrate transporters
JJFP Luiken et al.
PFLUGERS ARCHIV-EUROPEAN JOURNAL OF PHYSIOLOGY (2004)
Role of calcium and AMP kinase in the regulation of mitochondrial biogenesis and GLUT4 levels in muscle
EO Ojuka
PROCEEDINGS OF THE NUTRITION SOCIETY (2004)
Disruption of leptin signaling contributes to cardiac hypertrophy independently of body weight in mice
LA Barouch et al.
CIRCULATION (2003)
Definition of a novel growth factor-dependent signal cascade for the suppression of bile acid biosynthesis
JA Holt et al.
GENES & DEVELOPMENT (2003)
Mechanisms of apoptosis in the heart
AB Gustafsson et al.
JOURNAL OF CLINICAL IMMUNOLOGY (2003)
Phosphatidylinositol 3-kinase regulates nuclear translocation of NF-E2-related factor 2 through actin rearrangement in response to oxidative stress
KW Kang et al.
MOLECULAR PHARMACOLOGY (2002)
Coupling endoplasmic reticulum stress to the cell death program: role of the ER chaperone GRP78
RV Rao et al.
FEBS LETTERS (2002)
Identification of a novel FGF, FGF-21, preferentially expressed in the liver
T Nishimura et al.
BIOCHIMICA ET BIOPHYSICA ACTA-GENE STRUCTURE AND EXPRESSION (2000)
Coupling of stress in the ER to activation of JNK protein kinases by transmembrane protein kinase IRE1
F Urano et al.
SCIENCE (2000)
Share Paper
